Published by Coherent Market Insights
Posted on September 21, 2021
Global Bone Graft Substitutes Market
Bone graft substitutes are materials used for the replacement of the missing bones or gum tissues in the body. These are used for filling the null areas of certain body parts, such as the knee, wrist, ribs, etc. The substitutes may be manmade or derived from a donor’s body. The common types of bone graft substitutes are allograft, xenograft, alloplast, and autograft. Allografts are tissues of the donors given to the recipients, but are often not the same as used in knees, hips, or long bones. Bone grafts are the synthetic type of a naturally-occurring substance. A wide variety of bone graft substitutes are available for use in spinal fusion surgery, which is categorized into three main areas, namely, Demineralized Bone Matrix (DBM), Bone Morphogenetic Proteins (BMP), and synthetic bone graft extenders.
The bone graft substitute is osteoinductive, biocompatible, and bioresorbable, and its structure is similar to actual bones. These are cost-effective and easy to use. Bone graft substitutes are extensively used in dental implants, fibular shafts, and others. The sources of bone grafts are Osteoconduction, Osteogenesis, Osteopromotion, and Osteoinduction. These are the biological mechanisms that provide a basis for bone grafting. The spinal fusion surgery is the most common surgery in this were it is used to correct hitches with the small bones of the vertebrae. Spinal fusion removes the motion between vertebrae and helps prevent the stretching of nerves, ligaments, and muscles.
Request For Sample Copy Here: https://www.coherentmarketinsights.com/insight/request-sample/427
Global Bone Graft Substitutes Market Segmentation
By application
By product type
By region
Increase in spinal fusion and osteoporosis procedures around the globe is a leading factor for the global bone graft substitutes market growth
Growing population and growing prevalence of bone and joint disorders are the pivotal factors boosting the global bone graft substitutes market development. According to the National Osteoporosis Foundation (NOF), the number of osteoporosis cases is expected to exceed 61 million by 2020. The National Spinal Cord Injury Center, U.S., reported that nearly 12500 new spinal cord injury (SCI) cases emerge each year. Moreover, the International Osteoporosis Foundation (IOF) estimated that around 50% of all osteoporotic hip fractures would be arising in Asia by the year 2050.
In India, the IOF estimated the number of osteoporosis patients to be approximately 26 million. Whereas, in Japan, the total number of hip fractures is estimated to be approximately 238,000 by 2030.
Get Flat USD 2000 OFF
Buy-Now this research report: https://www.coherentmarketinsights.com/promo/buynow/427
Reasons to Purchase this Report:
Current and future of global Cancer Registry Software Market outlook in the developed and emerging markets
The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period.
Regions/countries that are expected to witness the fastest growth rates during the forecast period.
The latest developments, market shares, and strategies that are employed by the major market players.
Key Players of the Global Bone Graft Substitutes Market
The well-known companies operating in the global bone graft substitutes market include Geistlich North America Inc., Medtronic BioHorizons IPH, ACE Surgical Supply Company, Stryker Corporation, RTI Surgical, Inc. LifeNet Health, Institut Straumann AG, Acesurgica Supply Co. Inc., and DePuySynthes.
Contact US:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837
The post Bone Graft Substitutes Market Valued at USD 1.78 Billion in 2020 and it is expected to expand At CAGR OF 4.3% by 2021-2027 appeared first on Gatorledger.
Global Bone Graft Substitutes Market
Bone graft substitutes are materials used for the replacement of the missing bones or gum tissues in the body. These are used for filling the null areas of certain body parts, such as the knee, wrist, ribs, etc. The substitutes may be manmade or derived from a donor’s body. The common types of bone graft substitutes are allograft, xenograft, alloplast, and autograft. Allografts are tissues of the donors given to the recipients, but are often not the same as used in knees, hips, or long bones. Bone grafts are the synthetic type of a naturally-occurring substance. A wide variety of bone graft substitutes are available for use in spinal fusion surgery, which is categorized into three main areas, namely, Demineralized Bone Matrix (DBM), Bone Morphogenetic Proteins (BMP), and synthetic bone graft extenders.
The bone graft substitute is osteoinductive, biocompatible, and bioresorbable, and its structure is similar to actual bones. These are cost-effective and easy to use. Bone graft substitutes are extensively used in dental implants, fibular shafts, and others. The sources of bone grafts are Osteoconduction, Osteogenesis, Osteopromotion, and Osteoinduction. These are the biological mechanisms that provide a basis for bone grafting. The spinal fusion surgery is the most common surgery in this were it is used to correct hitches with the small bones of the vertebrae. Spinal fusion removes the motion between vertebrae and helps prevent the stretching of nerves, ligaments, and muscles.
Request For Sample Copy Here: https://www.coherentmarketinsights.com/insight/request-sample/427
Global Bone Graft Substitutes Market Segmentation
By application
By product type
By region
Increase in spinal fusion and osteoporosis procedures around the globe is a leading factor for the global bone graft substitutes market growth
Growing population and growing prevalence of bone and joint disorders are the pivotal factors boosting the global bone graft substitutes market development. According to the National Osteoporosis Foundation (NOF), the number of osteoporosis cases is expected to exceed 61 million by 2020. The National Spinal Cord Injury Center, U.S., reported that nearly 12500 new spinal cord injury (SCI) cases emerge each year. Moreover, the International Osteoporosis Foundation (IOF) estimated that around 50% of all osteoporotic hip fractures would be arising in Asia by the year 2050.
In India, the IOF estimated the number of osteoporosis patients to be approximately 26 million. Whereas, in Japan, the total number of hip fractures is estimated to be approximately 238,000 by 2030.
Get Flat USD 2000 OFF
Buy-Now this research report: https://www.coherentmarketinsights.com/promo/buynow/427
Reasons to Purchase this Report:
Current and future of global Cancer Registry Software Market outlook in the developed and emerging markets
The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period.
Regions/countries that are expected to witness the fastest growth rates during the forecast period.
The latest developments, market shares, and strategies that are employed by the major market players.
Key Players of the Global Bone Graft Substitutes Market
The well-known companies operating in the global bone graft substitutes market include Geistlich North America Inc., Medtronic BioHorizons IPH, ACE Surgical Supply Company, Stryker Corporation, RTI Surgical, Inc. LifeNet Health, Institut Straumann AG, Acesurgica Supply Co. Inc., and DePuySynthes.
Contact US:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837
The post Bone Graft Substitutes Market Valued at USD 1.78 Billion in 2020 and it is expected to expand At CAGR OF 4.3% by 2021-2027 appeared first on Gatorledger.
Explore more articles in the Research Reports category
